Trauma News and Research

RSS

DFG to establish eight new Collaborative Research Centres

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) will establish eight new Collaborative Research Centres (CRCs).

2 Dec 2014

Baxter seeks FDA approval of BAX 855 for treatment of people with hemophilia A

Nektar Therapeutics reported that partner Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) to the United States Food and Drug Administration for the approval of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)].

From Baxter International Inc. 1 Dec 2014

Clementia's palovarotene receives FDA Fast Track designation for FOP treatment

Clementia Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has granted Fast Track designation to palovarotene, which is being developed for the treatment of fibrodysplasia ossificans progressiva (FOP).

1 Dec 2014

Grand Challenges Canada announces $1.2 million in grant for 11 new global health innovations

Grand Challenges Canada, funded by the Government of Canada, today announced $1.2 million in funding for 11 new global health innovations implemented in member states of La Francophonie.

29 Nov 2014

DFG to establish new Collaborative Research Centres

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) will establish eight new Collaborative Research Centres (CRCs).

29 Nov 2014

US Special Forces funding breakthrough drug therapy for treating wounded soldiers

US Special Forces are funding a world first, breakthrough drug therapy for treating battle casualties that's being developed by James Cook University scientists in Australia.

27 Nov 2014

GABA injections prevent and reverse Type 1 diabetes in mice

A chemical produced in the pancreas that prevented and even reversed Type 1 diabetes in mice had the same effect on human beta cells transplanted into mice, new research has found.

27 Nov 2014

Innovative collar for MND patients to be showcased at NHS Innovation Challenge Prizes

MEDICAL technology designers are to pitch a new contoured support snood helping to improve the quality of lives of motor neurone disease sufferers whose neck muscles have weakened to a panel of Dragons’ Den style judges as part of a £10,000 innovation challenge.

27 Nov 2014

Researchers say that nervous system may play vital role in infections, autoimmune diseases

The nervous system may play a bigger role in infections and autoimmune diseases than previously known. If researchers can learn more about that role, it could provide insight into diagnosing and treating everything from the stomach flu to rheumatoid arthritis.

27 Nov 2014

Abnormal vitamin D, trace element levels may indicate asthma risk

Serum levels of vitamin D, copper and zinc could help identify infants with recurrent wheezing who are at risk of developing asthma, Turkish researchers suggest.

25 Nov 2014

New, enhanced MRI identifies brain injury in BBB of football players following mild concussions

A new, enhanced MRI diagnostic approach was, for the first time, able to identify significant damage to the blood-brain barrier (BBB) of professional football players following "unreported" trauma or mild concussions. Published in the current issue of JAMA Neurology, this study could improve decision making on when an athlete should "return to play."

24 Nov 2014

Researchers make significant breakthrough for sufferers of bone disease

Researchers in bone tissue regeneration believe they have made a significant breakthrough for sufferers of bone trauma, disease or defects such as osteoporosis.

24 Nov 2014

Clementia gets Orphan Medicinal Product Designation from EMA for palovarotene

Clementia Pharmaceuticals, Inc. announced today that the European Medicines Agency (EMA) has granted Orphan Medicinal Product Designation for palovarotene, the company's lead product candidate, for the treatment of fibrodysplasia ossificans progressiva (FOP).

21 Nov 2014

EvergreenHealth, Valley General Hospital approve final phase of alliance agreement

EvergreenHealth and Valley General Hospital announced today that their respective Boards of Commissioners have voted to approve the third and final phase of an alliance agreement in which Valley General Hospital in Monroe, Washington will become part of the Kirkland-based health care system and managed by EvergreenHealth.

19 Nov 2014

Synovasure PJI Alpha Defensin Test now available for sale in Europe

Zimmer today announced Synovasure PJI Alpha Defensin Test for Periprosthetic Joint Infection, the first and only test specifically designed for the diagnosis of Periprosthetic Joint Infection (PJI), is now eligible for sale in several European countries after earning key overseas certification this month.

19 Nov 2014

Physical pain and social pain use distinct neural circuits, new study reveals

Over the last decade, neuroscientists have largely come to believe that physical pain and social pain are processed by the brain in the same way. But a new study led by the University of Colorado shows that the two kinds of pain actually use distinct neural circuits, a finding that could lead to more targeted treatments and a better understanding of how the two kinds of pain interact.

19 Nov 2014

Research breakthrough offers hope for patients with severe spinal cord injuries

Case Western Reserve researchers have developed a procedure that restores function to muscles involved in the control of breathing - even when they have been paralyzed for more than a year. The breakthrough offers hope that one day patients with severe spinal cord injuries will be able to breathe again without the assistance of a ventilator.

19 Nov 2014

Scientists identify defects in colossal heart protein which leads to stroke, heart failure

The landmark discovery of a tiny defect in a vital heart protein has for the first time enabled heart specialists to accurately pinpoint a therapeutic target for future efforts in developing a drug-based cure for cardiovascular diseases.

18 Nov 2014

VEGF-B can regenerate damaged peripheral nerves without causing growth of new blood vessels

Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels -- making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.

18 Nov 2014

Spinal cord injuries can cause brain degeneration, find UM SOM researchers

Most research on spinal cord injuries has focused on effects due to spinal cord damage and scientists have neglected the effects on brain function. University of Maryland School of Medicine researchers have found for the first time that spinal cord injuries (SCI) can cause widespread and sustained brain inflammation that leads to progressive loss of nerve cells, with associated cognitive problems and depression.

17 Nov 2014

Trauma News and Research

DFG to establish eight new Collaborative Research Centres

Baxter seeks FDA approval of BAX 855 for treatment of people with hemophilia A

Clementia's palovarotene receives FDA Fast Track designation for FOP treatment

Grand Challenges Canada announces $1.2 million in grant for 11 new global health innovations

DFG to establish new Collaborative Research Centres

US Special Forces funding breakthrough drug therapy for treating wounded soldiers

GABA injections prevent and reverse Type 1 diabetes in mice

Innovative collar for MND patients to be showcased at NHS Innovation Challenge Prizes

Researchers say that nervous system may play vital role in infections, autoimmune diseases

Abnormal vitamin D, trace element levels may indicate asthma risk

New, enhanced MRI identifies brain injury in BBB of football players following mild concussions

Researchers make significant breakthrough for sufferers of bone disease

Clementia gets Orphan Medicinal Product Designation from EMA for palovarotene

EvergreenHealth, Valley General Hospital approve final phase of alliance agreement

Synovasure PJI Alpha Defensin Test now available for sale in Europe

Physical pain and social pain use distinct neural circuits, new study reveals

Research breakthrough offers hope for patients with severe spinal cord injuries

Scientists identify defects in colossal heart protein which leads to stroke, heart failure

VEGF-B can regenerate damaged peripheral nerves without causing growth of new blood vessels

Spinal cord injuries can cause brain degeneration, find UM SOM researchers

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News